e8vk
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): August 31, 2006
|
|
|
EPIX Pharmaceuticals, Inc. |
(Exact Name of Registrant as Specified in its Charter) |
|
|
|
|
Delaware |
(State or Other Jurisdiction of Incorporation) |
|
|
|
|
000-21863 |
|
04-3030815 |
(Commission File Number)
|
|
(IRS Employer Identification No.) |
|
|
|
|
|
|
4 Maguire Road, Lexington, Massachusetts |
|
02421 |
(Address of Principal Executive Offices)
|
|
(Zip Code) |
|
|
|
Registrants telephone number, including area code: (781) 372-3260
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 1.01 Entry into a Definitive Material Agreement.
On August 31, 2006, EPIX Pharmaceuticals, Inc. (the Company), through its wholly-owned
subsidiary, EPIX Delaware, Inc., entered into an amendment (the Amendment) to the lease, dated
January 25, 2005, between Predix Pharmaceuticals Holdings, Inc. and the Trustees of 4 Maguire Road
Realty Trust for the premises located at 4 Maguire Road, Lexington Massachusetts 02421 (the
Lease). The Amendment expands the total administrative office and laboratory space under the
Lease from approximately 29,131 square feet to approximately 57,303 square feet. In addition, the
Amendment extends the term of the Lease through October 15,
2013, subject to extension due to the completion of certain
improvements for the expanded space. The term of the Lease may also
be extended by the parties for two
additional periods of three years each. The annual base rent for the prior space under the Lease
is $474,500 through December 14, 2006, which amount increases annually over the term
of the Lease. Following the completion of certain improvements for the expanded space under the
Amendment, the annual base rent for the premises will increase by an
additional $577,500, which amount also increases annually over the term of the Lease.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
EPIX PHARMACEUTICALS, INC.
|
|
September 7, 2006 |
By: |
/s/ Kimberlee C. Drapkin
|
|
|
|
Kimberlee C. Drapkin |
|
|
|
Chief Financial Officer |
|
|